Open AccessRestoring Fertility in Cancer Survivors: Ovarian Tissue Cryopreservation or Assisted Reproduction Technique
Author(s) -
Divyashree Ps,
Khushboo Priya
Publication year - 2017
Publication title -
international journal of infertility and fetal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.102
H-Index - 6
eISSN - 2229-3833
pISSN - 2229-3817
DOI - 10.5005/jp-journals-10016-1143
Subject(s) - oocyte cryopreservation , fertility preservation , fertility , ovarian tissue cryopreservation , cryopreservation , embryo cryopreservation , medicine , reproduction , gynecology , live birth , infertility , assisted reproductive technology , pregnancy , andrology , obstetrics , embryo , biology , population , environmental health , genetics , ecology , microbiology and biotechnology
Fertility restoration in cancer patients is gaining a very important role in the field of reproductive medicine, due to the rising incidence of cancer as well as its early detection and improved survival rate. The two options for achieving this aim are ovarian tissue cryopreservation (OTC) and assisted reproductive treatment (ART) through oocyte or embryo cryopreservation after IVF. However, both these have some advantages and disadvantages over each other. OTC is still in experimental phase but is growing faster as an important part of fertility restoration. ART is time tested method which can be relied upon to a great extent, but there are some situations where ART cannot meet the expectations. This review is an overview of the pros and cons of both these options and the status of these methods in the present scenario of fertility preservation. How to cite this article Priya K, Divyashree PS. Restoring Fertility in Cancer Survivors: Ovarian Tissue Cryopreservation or Assisted Reproduction Technique. Int J Infertil Fetal Med 2017;8(1):24-31.